Subject : A survey to understand the perception and practice of primary care physicians in management of lower urinary tract symptoms (LUTS)
Benign prostatic hyperplasia (BPH) is the most common urological condition, and benign enlargement in men older than 50 years of age. (Chute GG et 1993) Bothersome LUTS (Lower Urinary Tract Symptoms) are associated with a negative impact on quality of life (QoL). (Chute GG et 1993) The progressive development of conservative therapy for male LUTS suggestive of BPH has shifted the paradigm of LUTS management. Conservative treatment is preferred for men with moderate to severe LUTS without absolute indications for invasive treatment. Physicians now have a wider role owing to increased numbers of conservative management options such as use of α-adrenergic antagonists (e.g., silodosin, tamsulosin, alfuzosin), 5α-reductase inhibitors (e.g., Dutasteride, Finasteride) and PDE5 inhibitors (e.g., tadalafil). These drugs have been known to improve LUTS and reduce serious complications in BPH patients such as acute urinary retention, urinary tract infection, and decreased renal function; hence, they may improve patients’ QoL and reduce the risk of these complications. (Emberton M et al 2008)
The objective of this survey is to evaluate current practice and perception of primary care physicians in management of lower urinary tract symptoms in India.
As you will be spending some extra time to give your feedback on the questionnaire based on your clinical experience, we offer to pay you by cheque a professional fee of INR {{$contractAmount}}, on receiving the completed Survey Questionnaire Form from you.
We trust you and we are partners in promoting safe and effective drug therapy. In that spirit we hope you will consent to participate in this study. If you do, please sign and return the enclosed reply along with your visiting card for accuracy of records.
|
}}){kind=logo}
}})